Pharvaris (PHVS) CEO Berndt Modig details stock, RSUs and options
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Pharvaris N.V. director and Chief Executive Officer Berndt Modig filed an initial ownership report showing his equity position in the company. He directly holds 165,417 shares of common stock, plus additional restricted stock units that vest over time. He also has indirect ownership of 950,000 common shares through Schoodic Management B.V., an entity he controls. In addition, he holds multiple stock option awards on common shares with exercise prices ranging from $8.05 to $28.00 and expiration dates between 2031 and 2036, providing long-dated upside exposure tied to the company’s share price.
Positive
- None.
Negative
- None.
Insider Trade Summary
8 transactions reported
Mixed
8 txns
Insider
Modig Berndt
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 210,000 shares (Direct);
Common Stock — 165,417 shares (Direct);
Common Stock — 950,000 shares (Indirect, By Schoodic Management BV)
Footnotes (1)
- Includes restricted stock units previously granted under the Company's equity plan that remain outstanding as of March 18, 2026. The awards settle in shares of common stock and are reported in Table I as non-derivative securities. Vesting occurs as follows: -70,000 RSUs from an award granted March 3, 2026 of which 25% will vest March 3, 2027 with the remainder vesting monthly thereafter; -45,000 RSUs from an award granted March 12, 2025 of which 25% vested March 12, 2026 with the remainder vesting monthly thereafter; -26,042 RSUs from an award granted April 11, 2024 of which 25% vested April 11, 2025 with the remainder vesting monthly thereafter. Schoodic Management B.V., an entity controlled by Mr. Modig 25% of the option will vest on March 3, 2027 with the remaining shares vesting in 1/48 monthly installments thereafter. 25% of the option vested on March 12, 2026 with the remaining shares vesting in 1/48 monthly installments thereafter. 25% of the option vested on April 11, 2025 with the remaining shares vesting in 1/48 monthly installments thereafter. 25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter. 25% of the option vested on April 1, 2023 with the remaining shares vesting in 1/48 monthly installments thereafter. 25% of the option vested on February 2, 2022 with the remaining shares vesting in 1/48 monthly installments thereafter.
FAQ
What does Berndt Modig’s Form 3 filing for Pharvaris (PHVS) show?
The filing shows Berndt Modig’s initial ownership in Pharvaris. He reports direct and indirect common stock holdings plus several long-term stock option grants, outlining his equity-based alignment with the company’s future performance.
What stock options does the Pharvaris (PHVS) CEO report on his Form 3?
The CEO reports several stock option awards on Pharvaris common shares with exercise prices between $8.05 and $28.00 and expiration dates from 2031 to 2036, giving him long-term participation in potential share price appreciation.
Does the Pharvaris (PHVS) Form 3 show any recent insider buying or selling?
The Form 3 is an initial ownership statement and does not show new purchases or sales. It lists Modig’s existing common stock, restricted stock units, and stock option positions as of the reporting date.
How are Schoodic Management B.V. holdings treated in the Pharvaris (PHVS) Form 3?
The filing reports 950,000 Pharvaris common shares held indirectly through Schoodic Management B.V. A footnote explains this entity is controlled by Berndt Modig, so those shares are attributed to him as indirect ownership.
What restricted stock units (RSUs) are outstanding for the Pharvaris (PHVS) CEO?
The filing notes multiple RSU awards outstanding as of March 18, 2026, including tranches granted in 2024, 2025, and 2026. Each grant vests 25% on a specified date, with the remaining units vesting in equal monthly installments thereafter.